Health in Lao People’s Democratic Republic 1,071 indicators covering health for Lao People’s Democratic Republic. IndicatorLatest Year10-yr change Rank Mean hemoglobin level of children aged 6-59 months 112 2019 up 0.9% 132nd Estimated number of MDR/RR-TB incident cases 48 2024 down 76.0% 114th Mortality caused by road traffic injury 17.9 per 100,000 population 2019 up 26.1% 75th Mortality caused by road traffic injury, female 9.7 per 100,000 female population 2019 up 15.5% 67th Mortality caused by road traffic injury, male 25.9 per 100,000 male population 2019 up 28.9% 79th Ipv vaccine coverage 63 2024 up 472.7% 180th Tb patients living with hiv receiving art 210 2021 down 2.3% 68th HIV-positive TB patients on ART (antiretroviral therapy) 76.0% 2024 down 2.6% 119th Hospital beds 17.13 2023 up 55.4% 100th Treatment success rate for patients treated for MDR-TB 76.0% 2022 up 100.0% 64th New leprosy case detection rate per 1 000 000 population 3.09 2024 down 79.5% 70th Treatment success rate: HIV-positive TB cases 77 2023 up 35.1% 67th Prevalence of wasting, weight for height 10.7% 2023 up 81.4% 9th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 52.0% 2025 — 152nd International Health Regulations core capacity scores, SPAR version 40 2025 — 112th Prevalence of underweight, weight for age 24.3% 2023 down 8.6% 8th Leprosy registered prevalence rate per 1 000 000 population 3.09 2024 down 77.3% 69th Leprosy - Number of new leprosy cases among children 0 2024 down 100.0% 69th Leprosy - Number of cases registered for treatment 24 2024 down 74.5% 70th New leprosy child case detection rate (less than 15 years of age) per 0 2024 down 100.0% 69th Children (0-14) living with HIV 760 2024 up 20.6% 60th Ipv1 number unvaccinated 49,157 2023 down 64.8% 52nd Children living with hiv 760 2024 up 20.6% 60th Contraceptive prevalence, any method 56.3% 2017 up 46.6% 59th Children (ages 0-14) newly infected with HIV 100 2024 down 50.0% 51st Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Number of children newly infected with hiv 100 2024 down 50.0% 51st Share of children under fifteen years old with hiv 70.34 2024 down 39.0% 54th Number of female leprosy new cases 8 2024 down 81.4% 65th Estimated number of malaria deaths 0 2024 down 100.0% 66th Estimated number of malaria cases 538 2024 down 99.4% 71st National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 up 100.0% 1st Contraceptive prevalence, any modern method 51.0% 2017 up 45.8% 49th Number of prevalent tuberculosis cases 31,000 2014 down 29.5% 43rd Estimated malaria incidence 0.1331 2024 down 99.5% 75th Estimated malaria mortality rate 0 2024 down 100.0% 66th Number of new G2D leprosy cases 6 2024 down 81.8% 57th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0.772 2024 down 84.6% 52nd Inflation-adjusted prices for most sold brand of cigarettes: Prices 2.26 2022 down 22.6% 167th Taxes as a % of price: total tax 15.4% 2022 down 22.7% 179th Taxes as a % of price: value added tax 9.1% 2022 unchanged 130th Taxes as a % of price: ad valorem excise 6.3% 2022 up 231.9% 94th Taxes as a % of price: specific excise 0.0% 2022 down 100.0% 134th Taxes as a % of price: import duties 0.0% 2022 — 37th Taxes as a % of price: other taxes 0.0% 2022 down 100.0% 56th Vitamin A supplementation coverage rate 36.0% 2022 down 23.4% 40th Inflation-adjusted prices for most sold brand of cigarettes: Price in 7,000 2022 down 28.2% 7th Estimated number of children needing antiretroviral therapy based on 760 2025 up 4.1% 60th Prevalence of severe wasting, weight for height 2.7% 2023 up 92.9% 5th Physical activity policies for activie societies 20 2023 unchanged 2nd Physical activity policies focused on active systems 10 2023 down 50.0% 99th Midwifery personnel 2,780 2024 up 175.0% 60th Number of deaths from malaria who 0 2024 down 100.0% 66th Death rate from malaria 0 2024 down 100.0% 66th Incidence of malaria 0.13 2024 down 99.5% 73rd Share of one year olds who received the final dose of pneumococcal vac 63 2024 down 7.4% 128th Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 63 2024 down 7.4% 128th Estimated antiretroviral therapy coverage among children 40 2025 up 33.3% 60th Death rate from poisonings 0.3 2021 down 25.0% 110th Share of deaths registered 46.78 2019 — 136th ← Previous Page 15 of 18 Next →